This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lewindon, P. J. Articles by Ramm, G. A. Search for Related Content PubMed PubMed Citation Articles by Lewindon, P. J. Articles by Ramm, G. A.

(American Journal of Pathology. 2002;160:1705-1715.)
© 2002 American Society for Investigative Pathology

Regular Articles

The Role of Hepatic Stellate Cells and Transforming Growth Factor-ß₁ in Cystic Fibrosis Liver Disease

Peter J. Lewindon^*, Tamara N. Pereira, Anita C. Hoskins, Kim R. Bridle, Richard M. Williamson, Ross W. Shepherd and Grant A. Ramm

From the Department of Gastroenterology,^*Royal Children’s Hospital, Brisbane, Australia; the Hepatic Fibrosis Group,The Queensland Institute of Medical Research, Herston, Australia; the Department of Histopathology,Royal Brisbane Hospital, Brisbane, Australia; and the Department of Pediatrics,Washington University School of Medicine, St. Louis, Missouri

Liver disease causes significant morbidity and mortality from multilobular cirrhosis in patients with cystic fibrosis. Abnormal bile transport and biliary fibrosis implicate abnormal biliary physiology in the pathogenesis of cystic fibrosis-associated liver disease (CFLD), yet the mediators linking biliary events to fibrosis remain unknown. Activated hepatic stellate cells (HSCs) are the pre-eminent mediators of fibrosis in a range of hepatic disorders. The dominant stimulus for matrix production by HSCs is the cytokine transforming growth factor (TGF)-ß₁. In CFLD, the role of HSCs and the source of TGF-ß₁ have not been evaluated. Liver biopsy tissue obtained from 38 children with CFLD was analyzed. Activated HSCs, identified by co-localization of procollagen ₁(I) mRNA and -smooth muscle actin, were demonstrated as the cellular source of excess collagen production in the fibrosis surrounding the bile ducts and the advancing edge of scar tissue. TGF-ß protein and TGF-ß₁ mRNA expression were shown to be predominantly expressed by bile duct epithelial cells. TGF-ß₁ expression was significantly correlated with both hepatic fibrosis and the percentage of portal tracts showing histological abnormalities associated with CFLD. This study demonstrates a definitive role for HSCs in fibrogenesis associated with CFLD and establishes a potential mechanism for the induction of HSC collagen gene expression through the production of TGF-ß₁ by bile duct epithelial cells.

This article has been cited by other articles:

				G. S. Belinsky, A. L. Parke, Q. Huang, K. Blanchard, S. Jayadev, R. Stoll, M. Rothe, L. E. K. Achenie, R. R. Gupta, G. Y. Wu, et al. The Contribution of Methotrexate Exposure and Host Factors on Transcriptional Variance in Human Liver Toxicol. Sci., June 1, 2007; 97(2): 582 - 594. [Abstract] [Full Text] [PDF]

				J. Y. Lee, H. L. Elmer, K. R. Ross, and T. J. Kelley Isoprenoid-Mediated Control of SMAD3 Expression in a Cultured Model of Cystic Fibrosis Epithelial Cells Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 234 - 240. [Abstract] [Full Text] [PDF]

				R. M. Clancy, C. B. Backer, X. Yin, R. P. Kapur, Y. Molad, and J. P. Buyon Cytokine Polymorphisms and Histologic Expression in Autopsy Studies: Contribution of TNF-{alpha} and TGF-{beta}1 to the Pathogenesis of Autoimmune-Associated Congenital Heart Block J. Immunol., September 15, 2003; 171(6): 3253 - 3261. [Abstract] [Full Text] [PDF]